Physician profile
Jyoti Bhatt
NPI 1669571592
$1,344.86
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $691 · 2021: $20.09.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $305.92 | 2019-2020 | |
| Amgen INC. | $221.82 | 2019-2021 | |
| Abbvie INC. | $187.16 | 2019-2020 | |
| Amarin Pharma, INC. | $109.35 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $78.68 | 2019-2020 | |
| Pfizer INC. | $71.01 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $64.49 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $61.72 | 2019-2020 | |
| Lilly USA, LLC | $39.85 | 2020 | |
| Astellas Pharma US INC | $37.27 | 2019 | |
| Allergan, INC. | $35.04 | 2020 | |
| Sanofi Pasteur INC. | $30.44 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $23.35 | 2019 | |
| Mylan Specialty L.P. | $16.17 | 2019 | |
| Bausch Health US, LLC | $14.17 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.71 | 2019 | |
| Hikma Pharmaceuticals USA | $12.66 | 2020 | |
| Circassia INC. | $11.14 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jyoti Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.